Researchers of Tomsk Polytechnic University have developed a radiopharmaceutical for highly accurate diagnosis of stomach cancer. It has been obtained using a technology that is completely new in Russia. The radiopharmaceutical is under clinical trials at the Oncology Research Institute of the Tomsk National Research Medical Center of the Russian Academy of Sciences. It can be used for selecting the most effective treatment for a particular patient.
The medicine has an original structure. It consists of a technetium-99 isotope, scaffolding protein and binding compounds. The protein can stick to certain areas of cancer cells and transfer technetium. So, technetium precisely indicates the malignant tumor location which is scanned through a gamma camera or single-photon emission computed tomography.
To bind scaffold protein with the isotope is a complex task...
Full text GMPnews.Net